Share Options (Immupharma)

Date : 02/04/2009 @ 7:32AM
Source : UK Regulatory (RNS and others)
Stock : Immupharma Plc (IMM)
Quote : 107.0  -2.75 (-2.51%) @ 11:35AM
<< BackQuote Chart

 



Share Options (Immupharma)

 
TIDMIMM 
 
RNS Number : 7889M 
Immupharma PLC 
04 February 2009 
 
? 
+--------------------------------------+--------------------------------------+ 
| For Immediate Release                |                      4 February 2009 | 
+--------------------------------------+--------------------------------------+ 
 
 
ImmuPharma PLC 
 
 
Grant of Options 
 
 
 
 
ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug 
discovery and development company, granted today share options to certain of its 
employees and Directors.  The Company has adopted a HM Revenue & Customs 
approved share ownership plan (CSOP) and an unapproved share option scheme. 
 
 
The amount of options granted are summarised in the following table: 
 
 
+--------------------------+--------------------------+ 
|        Director          |     Options Granted      | 
+--------------------------+--------------------------+ 
|      Richard Warr        |         140,000          | 
+--------------------------+--------------------------+ 
|      Robert Zimmer       |         150,000          | 
+--------------------------+--------------------------+ 
|    Dimitri Dimitriou     |         140,000          | 
+--------------------------+--------------------------+ 
|     Franco di Muzio      |         100,000          | 
+--------------------------+--------------------------+ 
|      Ajay Agrawal        |         100,000          | 
+--------------------------+--------------------------+ 
 
 
The share options provide the right to subscribe for ordinary shares of 10 pence 
each in the Company at a price of 86.5 pence each, the closing middle market 
price on 3 February 2009. The options are exercisable between 3 years and 10 
years from the date of grant. 
 
 
 
 
For further information, please contact: 
 
 
ImmuPharma PLC 
Dimitri Dimitriou, Chief Executive Officer020 7152 4080 
Richard Warr, Chairman020 7152 4080 
Dr Robert Zimmer, President & Chief Scientific Officer+33 389 32 76 50 
 
 
Panmure Gordon & Co (Nominated Advisor and Broker) 
Andrew Burnett / Rakesh Sharma (Corporate Finance)      020 7459 3600 
Ashton Clanfield (Corporate Broking) 
 
 
Buchanan Communications  020 7466 5000 
Lisa Baderoon 
Rebecca Skye Dietrich 
 
 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 RDSFGGGZZDMGLZM 
 
<< Back


Immupharma Plc Historical Chart Immupharma Plc Intraday Chart  
Period


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2009 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
43 site:2us 091122 01:26 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 )